nature-biotechnology
Nature Biotechnology (nature-biotechnology)
Journal positioning
Nature Biotechnology is the Nature Portfolio's venue for enabling technologies, platforms, and methods that have broad applied impact across biological research, medicine, or industry — with the distinguishing emphasis on translational potential and broad adoption at scale. Where Nature Methods' primary criterion is generalizable methodological advance for research, Nature Biotechnology additionally asks whether the technology could be (or already is) transformative for a wider application domain: therapeutics, diagnostics, agriculture, bioindustrial production, or research infrastructure. Papers must demonstrate both technical rigor and a compelling case for broad utility. The readership spans researchers, clinicians, engineers, and industry scientists.
This skill is a fit / venue-selection / re-framing tool. It does not replace the journal's current official submission guidelines. Before submitting, re-check the live author instructions on the Nature Portfolio site or submission system.
When to trigger
- The author names Nature Biotechnology as the target venue.
- A new platform technology, cell-engineering approach, or therapeutic tool is being assessed for venue fit against Nature Methods, Nature Medicine, or Cell Chemical Biology.
- A study delivering a biotechnological platform with demonstrated in vivo proof-of-concept needs to assess its significance level.
- The author needs Nature Biotechnology's specific desk-reject risks and re-routing options.